Find Press / Media

Search results

• Stillbirth incidence increases during COVID-19 pandemic

  Shannon Clark

  7/17/20

  2 items of Media coverage

  Press/Media: Expert Comment

• University of Texas Medical Branch: Zika Virus Hijacks the Host Cell's Own Defense Mechanism to Cause Disease

  Marc Morais, Shannan Rossi, Xuping Xie & Sarah van Tol

  7/17/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Zika virus hijacks the host cells own defense mechanism to cause disease

  Marc Morais, Shannan Rossi, Xuping Xie & Sarah van Tol

  7/17/20

  1 item of Media coverage

  Press/Media: Expert Comment

• A panel’s take on instruments, connectivity, COVID

  Michael Laposata

  7/16/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Opinion: Coronavirus Pandemic Highlights Dangers of Health Disparities

  Matthew Dacso

  7/16/20

  1 item of Media coverage

  Press/Media: Expert Comment

• A ‘catch and kill’ filter to control coronavirus indoors

  William Lawrence

  7/15/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Young people are leading the rise of COVID cases in Michigan. Here's what it means.

  Neil Mehta

  7/15/20

  1 item of Media coverage

  Press/Media: Expert Comment

• UTMB researchers have discovered a new antiviral mechanism for dengue therapeutics

  Kyung Choi, Xuping Xie, William Russell & Mark White

  7/13/20 → 7/14/20

  4 items of Media coverage

  Press/Media: Expert Comment

• BioSig Technologies: Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites

  Cheng Huang & John Manning

  7/13/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Opinion: Coronavirus Pandemic Highlights Dangers of Heath Disparities

  Matthew Dacso

  7/13/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Phase II Human Trial Of ViralClear's Anti-Viral For SARS-CoV-2 Coronavirus Underway At 4 Key Trial Sites

  Cheng Huang & John Manning

  7/13/20

  19 items of Media coverage

  Press/Media: Expert Comment

• Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites Nasdaq:BSGM

  Cheng Huang & John Manning

  7/13/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Virus strikes disproportionate blow in Latino community

  Shannon Guillot-Wright

  7/12/20 → 7/13/20

  2 items of Media coverage

  Press/Media: Expert Comment

• Coronavirus headlines: Where the pandemic is hitting Houston the hardest; More testing needed?

  Shannon Guillot-Wright

  7/11/20

  2 items of Media coverage

  Press/Media: Expert Comment

• Hispanic community being hit hardest by COVID-19

  Shannon Guillot-Wright

  7/9/20

  1 item of Media coverage

  Press/Media: Expert Comment

• ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19

  Cheng Huang & John Manning

  7/8/20 → 7/9/20

  13 items of Media coverage

  Press/Media: Expert Comment

• ViralClear Pharmaceuticals Partners With Albany Molecular Research (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19

  Cheng Huang & John Manning

  7/8/20

  2 items of Media coverage

  Press/Media: Expert Comment

• ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. On The Manufacture Of Merimepodib Active Pharmaceutical Ingredient Development For The Potential Treatment Of COVID-19

  Cheng Huang & John Manning

  7/7/20 → 7/8/20

  16 items of Media coverage

  Press/Media: Expert Comment

• ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM

  Cheng Huang & John Manning

  7/8/20

  2 items of Media coverage

  Press/Media: Expert Comment

• ViralClear Pharmaceuticals Partners with Albany Molecular Research on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19

  Cheng Huang & John Manning

  7/8/20

  3 items of Media coverage

  Press/Media: Expert Comment

• BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering

  Cheng Huang & John Manning

  6/28/20 → 6/30/20

  17 items of Media coverage

  Press/Media: Expert Comment

• BioSig Technologies Closes $17.5 Million Common Stock Offering

  Cheng Huang & John Manning

  6/29/20

  1 item of Media coverage

  Press/Media: Expert Comment

• Closes $17.5 Million Common Stock Offering

  Cheng Huang & John Manning

  6/29/20

  3 items of Media coverage

  Press/Media: Expert Comment

• SARS-CoV-2 From Patient With Coronavirus Disease, U.S.

  Shinji Makino, Steven Widen & Kenneth Plante

  6/29/20

  2 items of Media coverage

  Press/Media: Expert Comment

• Hospitals in Galveston County say space is adequate, despite warnings, rising cases

  Benny Raimer & Gulshan Sharma

  6/26/20

  1 item of Media coverage

  Press/Media: Expert Comment